Breast Cancer News and Research

Latest Breast Cancer News and Research

Study explores link between BPA exposure and breast cancer

Chronic low-level exposure to a compound found in a variety of plastic household items could pose a threat to women who overproduce a protein linked with breast cancer, say researchers at University of Alabama at Birmingham.

13 Oct 2011

Breast-reconstruction procedure can preserve mammary artery for future cardiac surgery

Doctors at Johns Hopkins have shown that during an increasingly popular type of breast-reconstruction surgery, they can safely preserve the internal mammary artery, in case it is needed for future cardiac surgery.

13 Oct 2011

VOA News examines how a public-private partnership will combat cancer among women in the developing world

This VOA News editorial examines how a public-private partnership between PEPFAR, the George W. Bush Institute, Susan G. Komen for the Cure, the Joint United Nations Programme on HIV/AIDS, as well as private sector partners will launch a program called Pink Ribbon, Red Ribbon to "combat cervical and breast cancer for women in sub-Saharan Africa and Latin America."

13 Oct 2011

NanoString introduces nCounter Analysis System

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the launch of its second generation nCounter Analysis System.

From NanoString Technologies 13 Oct 2011

Intellikine commences INK1117 Phase I dose escalation study in cancer

Intellikine, Inc., a company focused on the discovery and development of innovative, small molecule drugs targeting the PI3K/mTOR pathway, announced today that the first patient has been treated in a Phase I dose escalation study of INK1117 in patients with advanced solid malignancies.

12 Oct 2011

First Edition: October 12, 2011

Kaiser Health News staff writer Christopher Weaver reports: "Competition is fiercest in places like Boston, where high-ranking plans are near their goal, but shades of this quality arms race are visible throughout the country. Insurers have rarely competed on quality measures, but as the federal government prepares to unleash an estimated $3 billion to $4 billion next year in bonus payments, the industry is following the money. Star-ratings are bleeding into bottom lines, board meetings, and corporate strategy as the insurers chase top scores."

12 Oct 2011

Ovarian cancer patients survive longer with BRCA2 mutation in tumors

Among women with a certain type of high-grade ovarian cancer, having BRCA2 genetic mutations, but not BRCA1, was associated with improved overall survival and improved response to chemotherapy, compared to women with BRCA wild-type, according to a study in the October 12 issue of JAMA.

12 Oct 2011

Breast cancer education and detection a challenge in Egypt

In this Washington Times Communities column, Anwaar Abdalla, a lecturer on Civilization and Cultural Affairs at Egypt's Helwan University, writes, "While breast cancer is a global issue, in Egypt, the figure for people suffering from breast cancer is alarming," adding, "According to official statistics of the National Cancer Institute (Cairo University), breast cancer accounts for 35.1 percent of the cases of cancer in Egypt."

12 Oct 2011

FDA grants Advaxis pre-IND meeting for ADXS-HER2 cancer immunotherapy

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been granted a pre-Investigational New Drug meeting with the U.S. Food and Drug Administration on November 22nd, 2011 to discuss the initial clinical development plan for ADXS-HER2, a construct for the treatment of HER2 expressing cancers.

12 Oct 2011

Roundup: Calif. insurer's Avastin decision; Kansas dental care; Gov. Brown vetoes nursing bill

Blue Shield of California will stop covering new Avastin prescriptions for breast cancer patients starting Oct. 17. Patients already on the drug will still be covered, and exceptions could be made for individual cases reviewed by a panel of cancer experts. The not-for-profit insurer cited an unprecedented vote by a U.S. Food and Drug Administration panel that found the drug was not effective enough against breast cancer to risk its potentially dangerous side effects.

12 Oct 2011

Merrimack begins MM-121 Phase 2 combination trial in HER2-negative breast cancer

Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a randomized Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, combined with paclitaxel in the neoadjuvant setting of HER2-negative breast cancer patients.

12 Oct 2011

DMC completes review of BioSante's LibiGel Phase III cardiovascular and breast cancer study

BioSante Pharmaceuticals, Inc., announced today that the independent Data Monitoring Committee (DMC) has completed the seventh unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study, which has completed enrollment of subjects.

11 Oct 2011

AIM at Melanoma applauds bill banning children from using indoor tanning beds

AIM at Melanoma, the largest international foundation dedicated to melanoma research and patient advocacy, applauds Governor Jerry Brown's signing today of Senate Bill 746, which now bans children under 18 from using indoor tanning beds. Tanning beds have been linked to the rapid rise in melanoma rates among 15-39 year olds.

10 Oct 2011

Beauty Encounter sponsors ACS's premier breast cancer event

Beauty Encounter, a premier online source for all things fragrance and beauty and specializing in hard-to-find niche products, sponsored the American Cancer Society's annual Making Strides Against Breast Cancer walk in the local Orange County event that took place on October 9, 2011 at the Segerstrom Center in Costa Mesa.

10 Oct 2011

Osteoporosis drug protects against bone damaging side effects of breast cancer medications

A new study has found that an osteoporosis drug protects against the bone damaging side effects of certain breast cancer medications. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that some breast cancer patients could take zoledronic acid in addition to their anti-cancer medications to maintain bone health.

10 Oct 2011

MicroRNA-101 can block autophagy in cancer cells

All cells in our body have a system that can handle cellular waste and release building blocks for recycling. The underlying mechanism is called autophagy and literally means "self-eating". Many cancer cells have increased the activity of this system and the increased release of building blocks equip the cancer cells with a growth advantage and can render them resistant towards treatment.

10 Oct 2011

Boehringer Ingelheim receives FDA approval for COMBIVENT RESPIMAT to treat COPD

Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved COMBIVENT RESPIMAT, a new, propellant-free inhaler product that uses a slow-moving mist to deliver the same active ingredients of COMBIVENT Inhalation Aerosol in a metered dose inhaler.

10 Oct 2011

Preventive task force panel will urge men to skip prostate screening, reports say

The U.S. Preventive Services Task Force is scheduled to issue this recommendation on Tuesday, but advance press reports indicate the expert panel will urge the federal government to change its current position to recommend that men under age 75 forgo this widely used test.

7 Oct 2011

First Edition: October 7, 2011

In today's headlines, reports about what the Institute of Medicine recommends in terms of the criteria and methods the Department of Health and Human Services should follow in developing the health law's essential benefits package.

7 Oct 2011

USPTO awards HistoRx two patents for methods of standardization of digital microscopy instruments

HistoRx, the leader in quantitative immunohistochemistry, advances its proprietary position in digital pathology through the recent issuance of US patents covering key features necessary for achievement of reproducible, standardized image analysis results.

7 Oct 2011

Breast Cancer News and Research

Latest Breast Cancer News and Research

Study explores link between BPA exposure and breast cancer

Breast-reconstruction procedure can preserve mammary artery for future cardiac surgery

VOA News examines how a public-private partnership will combat cancer among women in the developing world

NanoString introduces nCounter Analysis System

Intellikine commences INK1117 Phase I dose escalation study in cancer

First Edition: October 12, 2011

Ovarian cancer patients survive longer with BRCA2 mutation in tumors

Breast cancer education and detection a challenge in Egypt

FDA grants Advaxis pre-IND meeting for ADXS-HER2 cancer immunotherapy

Roundup: Calif. insurer's Avastin decision; Kansas dental care; Gov. Brown vetoes nursing bill

Merrimack begins MM-121 Phase 2 combination trial in HER2-negative breast cancer

DMC completes review of BioSante's LibiGel Phase III cardiovascular and breast cancer study

AIM at Melanoma applauds bill banning children from using indoor tanning beds

Beauty Encounter sponsors ACS's premier breast cancer event

Osteoporosis drug protects against bone damaging side effects of breast cancer medications

MicroRNA-101 can block autophagy in cancer cells

Boehringer Ingelheim receives FDA approval for COMBIVENT RESPIMAT to treat COPD

Preventive task force panel will urge men to skip prostate screening, reports say

First Edition: October 7, 2011

USPTO awards HistoRx two patents for methods of standardization of digital microscopy instruments

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in